Materialise logo
Materialise
MTLS | NASDAQ
Chart Builder DCF Calculator
$6.21
-$0.28 (-4.31%)
At close: Nov 16, 2026, 4:00 PM ET
$6.21
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Materialise Company Profile

Company profile explained

Company Profile

Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.

Key Executives

Name Position
Brigitte de Vet-Veithen Chief Executive Officer
Johan Pauwels Executive Vice President & Chief Operating Officer
Koen Berges Chief Financial Officer
Annelies Missotten Chief Human Resources Officer
Bart Van der Schueren Chief Strategy & Technology Officer and Executive Vice President
Carla Van Steenbergen Executive Vice President, Director of Corporate Affairs, Compliance Officer & Secretary
Jurgen Laudus Executive Vice President of Manufacturing
Koen Peters Executive Vice President of Medical
Philippe Verlinde Chief Digital Information Officer
Udo Eberlein Executive Vice President of Software
Valérie Nerinckx Interim HR Director & CHRO
Wilfried Vancraen Founder & Chairman

Latest SEC Filings

Date Type Title
Oct 29, 2026 6-K Filing
Oct 28, 2026 6-K Filing
Oct 26, 2026 6-K Filing
Oct 20, 2026 6-K Filing
Oct 13, 2026 6-K Filing
Oct 05, 2026 6-K Filing
Sep 28, 2026 6-K Filing
Sep 21, 2026 6-K Filing
Sep 14, 2026 6-K Filing
Sep 08, 2026 6-K Filing
View All SEC Filings ➞
Materialise
Materialise logo
Country Belgium
IPO Date Jun 25, 2014
Industry Software - Application
Sector Technology
Employees 2,556
CEO Brigitte de Vet-Veithen

Contact Details

Technologielaan 15 Leuven, VL 3001 Belgium

Stock Details

Ticker Symbol MTLS
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001091223
CUSIP Number 57667T100
ISIN Number US57667T1007
SIC Code 7372

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.